224
Views
21
CrossRef citations to date
0
Altmetric
Original Article

No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan

, , , , , , , , , , , , & show all
Pages 945-952 | Received 17 May 2012, Accepted 10 Sep 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Moeko Ochiai, Eiichi Tanaka, Eri Sato, Eisuke Inoue, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Yoko Higuchi, Rei Yamaguchi, Naoki Sugimoto, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka & Masayoshi Harigai. (2021) Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings. Modern Rheumatology 31:4, pages 790-795.
Read now
Hisashi Yamanaka, Eiichi Tanaka, Ayako Nakajima, Takefumi Furuya, Katsunori Ikari, Atsuo Taniguchi, Eisuke Inoue & Masayoshi Harigai. (2020) A large observational cohort study of rheumatoid arthritis, IORRA: Providing context for today’s treatment options. Modern Rheumatology 30:1, pages 1-6.
Read now
Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong-Beom Park, Kwang-Hyub Han & Sang-Won Lee. (2020) Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study. Modern Rheumatology 30:1, pages 70-77.
Read now
Yoko Shimizu, Eiichi Tanaka, Eisuke Inoue, Kumi Shidara, Naoki Sugimoto, Yohei Seto, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi & Hisashi Yamanaka. (2018) Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort. Modern Rheumatology 28:3, pages 461-467.
Read now
Kensuke Ochi, Takuji Iwamoto, Asami Saito, Katsunori Ikari, Yoshiaki Toyama, Atsuo Taniguchi, Hisashi Yamanaka & Shigeki Momohara. (2015) Construct validity, reliability, response rate, and association with disease activity of the quick disabilities of the arm, shoulder and hand questionnaire in the assessment of rheumatoid arthritis. Modern Rheumatology 25:2, pages 241-245.
Read now

Articles from other publishers (16)

Eri Sugano, Eiichi Tanaka, Eisuke Inoue, Suguru Honda, Mai Abe, Kumiko Saka, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari & Masayoshi Harigai. (2023) Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort. Rheumatology.
Crossref
Hideyuki Shiba, Takuya Kotani, Koji Nagai, Kenichiro Hata, Wataru Yamamoto, Ayaka Yoshikawa, Yumiko Wada, Yuri Hiramatsu, Hidehiko Makino, Yo Ueda, Akira Onishi, Koichi Murata, Hideki Amuro, Yonsu Son, Ryota Hara, Toru Hirano, Kosuke Ebina, Masaki Katayama, Motomu Hashimoto & Tohru Takeuchi. (2023) Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study. International Journal of Molecular Sciences 24:8, pages 7399.
Crossref
Takafumi Suda. (2020) 炎症性疾患に対する生物学的製剤と呼吸器疾患診療の手引き(第2版). Nihon Naika Gakkai Zasshi 109:12, pages 2531-2538.
Crossref
M. Sezai TAŞBAKAN. (2019) Biyolojik ajanların pulmoner komplikasyonlarıPulmonary complications of biological agents. Ege Tıp Dergisi, pages 13-14.
Crossref
Takuya Matsumoto, Shingo Iwano, Nobunori Takahashi, Shuji Asai, Tatsuo Watanabe, Nobuyuki Asai, Yasumori Sobue, Satoru Ito, Naoki Ishiguro & Toshihisa Kojima. (2018) Association between chest computed tomography findings and respiratory adverse events in rheumatoid arthritis patients undergoing long‐term biological therapy. International Journal of Rheumatic Diseases 22:4, pages 626-635.
Crossref
Takahisa Gono. 2018. Lung Disease Associated with Rheumatoid Arthritis. Lung Disease Associated with Rheumatoid Arthritis 81 90 .
Hitoshi Tokuda. 2018. Lung Disease Associated with Rheumatoid Arthritis. Lung Disease Associated with Rheumatoid Arthritis 11 32 .
Sadatomo Tasaka. 2018. Lung Disease Associated with Rheumatoid Arthritis. Lung Disease Associated with Rheumatoid Arthritis 187 199 .
Yutaka Tsuchiya & Hironori Sagara. 2018. Lung Disease Associated with Rheumatoid Arthritis. Lung Disease Associated with Rheumatoid Arthritis 151 164 .
Takahisa Gono. 2018. Lung Disease Associated with Rheumatoid Arthritis. Lung Disease Associated with Rheumatoid Arthritis 3 7 .
Hisashi Yamanaka, Eiichi Tanaka, Ayako Nakajima, Takefumi Furuya, Katsunori Ikari & Atsuo Taniguchi. (2017) Achievements from a large cohort study of rheumatoid arthritis関節リウマチの大規模コホート研究とその成果. Nihon Naika Gakkai Zasshi 106:12, pages 2638-2644.
Crossref
Hitoshi Tokuda, Masayoshi Harigai, Hideto Kameda, Kazunori Tomono, Noboru Takayanagi, Akira Watanabe, Sadatomo Tasaka, Takafumi Suda, Kazuhiro Tateda & Junichi Kadota. (2017) Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]. Respiratory Investigation 55:3, pages 229-251.
Crossref
Lydia Abasolo, Jose Ivorra-Cortes, Leticia Leon, Juan A. Jover, Benjamin Fernandez-Gutierrez & Luis Rodriguez-Rodriguez. (2016) Influence of demographic and clinical factors on the mortality rate of a rheumatoid arthritis cohort: A 20-year survival study. Seminars in Arthritis and Rheumatism 45:5, pages 533-538.
Crossref
Kensuke Ochi, Takefumi Furuya, Mina Ishibashi, Makiko Watanabe, Katsunori Ikari, Atsuo Taniguchi, Hisashi Yamanaka & Shigeki Momohara. (2015) Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures. Rheumatology International 36:2, pages 213-219.
Crossref
Takafumi Suda & Hitoshi Tokuda. (2016) . Nihon Naika Gakkai Zasshi 105:8, pages 1414-1421.
Crossref
Noboru Takayanagi,. (2015) Biological agents and respiratory infections: Causative mechanisms and practice management. Respiratory Investigation 53:5, pages 185-200.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.